The House of Representatives overwhelmingly passed a USD 8.3 billion emergency funding bill to help contain and treat the novel coronavirus outbreak in the United States.
The measure passed with a 415-2 vote on Wednesday afternoon (local time) will head to the Senate for an expected swift vote on Thursday.
Eleven people have died from the novel coronavirus in the United States and more than 100 people have been confirmed infected. More than 90,000 people have been infected with the virus worldwide and more than 3,100 have died from complications associated with the infection.
The bill includes USD 3 billion to develop vaccines, therapeutics and diagnostics for coronavirus; USD 2.2 billion for public health response efforts; USD 1 billion for medical supplies and other health care preparedness efforts.
In addition, the bill includes low-interest loans to help small businesses survive the economic damages brought on by the crisis. It also includes USD 1.25 billion to help in overseas efforts to contain the outbreak.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
